First intention high-frequency oscillatory and conventional mechanical ventilation in premature infants without

Vincenzo Salvo1, Luc J Zimmermann, Antonio W Gavilanes

  • 1Department of Maternal, Fetal and Neonatal Medicine, University of Messina, Messina, Italy.

Insights

High-frequency oscillatory ventilation significantly reduced ventilator dependency, reintubation rates, and hospital stays for very low birth weight infants with respiratory distress syndrome when antenatal glucocorticoids were not used.

Area of Science:

  • Neonatal Medicine
  • Pediatric Respiratory Medicine
  • Critical Care

Background:

  • The effectiveness of high-frequency oscillatory ventilation (HFOV) versus conventional mechanical ventilation (CMV) for very low birth weight (VLBW) infants with respiratory distress syndrome (RDS) remains debated.
  • Antenatal glucocorticoid prophylaxis is a standard treatment for RDS, but its absence necessitates alternative management strategies.

Purpose of the Study:

  • To compare the efficacy of first-intention HFOV versus CMV in VLBW infants with RDS who did not receive antenatal glucocorticoid prophylaxis.
  • To evaluate primary and secondary outcomes, including ventilatory support duration, reintubation rates, and length of hospital stay.

Main Methods:

  • A multicenter randomized controlled trial was conducted involving 88 VLBW infants with RDS.
  • Infants were randomized to receive either HFOV (n=44) or CMV (n=44) as initial ventilatory support.
  • Standard monitoring, laboratory variables, neurologic assessments, and ultrasound imaging were employed.

Main Results:

  • HFOV significantly reduced ventilator dependency, reintubation rates, and postextubation nasal continuous positive airway pressure support duration compared to CMV.
  • VLBW infants treated with HFOV also showed a significantly lower need for repeat surfactant administration and shorter neonatal intensive care unit (NICU) and hospital stays.
  • No significant differences were reported for other adverse pulmonary and neonatal outcomes.

Conclusions:

  • First-intention HFOV is a beneficial strategy for VLBW infants with severe RDS who have not received antenatal glucocorticoid prophylaxis.
  • HFOV reduces the need for ventilatory support, surfactant therapy, and reintubation, while also shortening NICU and hospital stays, potentially lowering healthcare costs.
Abstract

Related Concept Videos

Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation (NIPPV)
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: